Baggott J E, Morgan S L, Koopman W J
University of Alabama at Birmingham, 35294, USA.
Arthritis Rheum. 1998 Aug;41(8):1407-10. doi: 10.1002/1529-0131(199808)41:8<1407::AID-ART9>3.0.CO;2-H.
To study the efficacy, toxicity, and antifolate activities of 7-hydroxymethotrexate (7-OH-MTX) versus methotrexate (MTX) in the treatment of rat adjuvant-induced arthritis.
Dose-dependent effects in rat adjuvant arthritis were determined by histologic and clinical examinations. Antifolate activity was determined by urinary levels of aminoimidazole carboxamide (AIC) as a marker for blockade of the folate-dependent enzyme, aminoimidazolecarboxamide ribotide transformylase (AICARTase).
MTX was 8 times more efficacious than 7-OH-MTX and resulted in higher urinary AIC levels. Increased urinary AIC levels were correlated with suppression of rat adjuvant arthritis regardless of the drug or dose level used.
The ability to metabolize MTX to 7-OH-MTX and the sensitivity of AICARTase to inhibition by 7-OH-MTX may at least partially account for the variability in response to MTX. Blocking of AICARTase may be important in the efficacy of these antifolates.
研究7-羟基甲氨蝶呤(7-OH-MTX)与甲氨蝶呤(MTX)治疗大鼠佐剂性关节炎的疗效、毒性及抗叶酸活性。
通过组织学和临床检查确定大鼠佐剂性关节炎中的剂量依赖性效应。以尿中氨基咪唑甲酰胺(AIC)水平作为叶酸依赖性酶氨基咪唑甲酰胺核糖核苷酸转化酶(AICARTase)被阻断的标志物来测定抗叶酸活性。
MTX的疗效比7-OH-MTX高8倍,且导致尿中AIC水平更高。无论使用何种药物或剂量水平,尿中AIC水平升高都与大鼠佐剂性关节炎的抑制相关。
MTX代谢为7-OH-MTX的能力以及AICARTase对7-OH-MTX抑制的敏感性可能至少部分解释了对MTX反应的变异性。阻断AICARTase可能对这些抗叶酸药物的疗效很重要。